Paradeep Phosphates Limited
NSE: PARADEEPMarket Closed • NSE
Day range
52 week range
Paradeep Phosphates Limited closed at INR147.16 (+0.51%) on volume 0.37x its 20-day average, trading 18.68% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved -14.5% QoQ
2026-09-04
DIVIDEND Announced
Dividend - Rs 1.50 Per Share
2025-08-22
DIVIDEND Announced
Dividend - Re 1 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
High Cash Flow Conversion: CFO/PAT averaged 1.18x over last 3 years
Attractive Valuation: P/E of 14.3x trades below sector historical averages
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Agricultural Inputs.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 04 Sept 2026 | Dividend | ₹1.50 / share | — | 04 Sept 2026 |
| 22 Aug 2025 | Dividend | ₹1.00 / share | — | 22 Aug 2025 |
| 18 Sept 2024 | Dividend | ₹0.50 / share | — | 17 Sept 2024 |
| 19 Sept 2023 | Dividend | ₹0.50 / share | — | 18 Sept 2023 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 UltraTech Cement LimitedULTRACEMCO Open analysis | ₹3.21L | 37.59 | 2.21% | ₹25,799.47 | ₹2,982.76 | +11.86% | +20.17% |
 JSW Steel LimitedJSWSTEEL Open analysis | ₹2.97L | 12.05 | 0.59% | ₹47,364.00 | ₹4,651.00 | +11.55% | +112.96% |
 Hindustan Zinc LimitedHINDZINC Open analysis | ₹2.28L | 13.37 | 2.07% | ₹13,687.00 | ₹5,425.00 | +77.22% | +146.14% |
 Asian Paints LimitedASIANPAINT Open analysis | ₹2.24L | 46.94 | 1.17% | ₹10,541.94 | ₹1,539.25 | +17.94% | +39.96% |
 Tata Steel LimitedTATASTEEL Open analysis | ₹2.19L | 19.83 | 2.27% | ₹60,794.00 | ₹2,385.00 | +14.32% | +18.83% |
 Hindalco Industries LimitedHINDALCO Open analysis | ₹2.02L | 12.32 | 0.56% | ₹84,825.00 | ₹7,013.00 | +32.06% | +75.15% |
 Grasim Industries LimitedGRASIM Open analysis | ₹1.98L | 34.82 | 0.35% | ₹11,794.71 | ₹246.65 | -70.60% | -82.61% |
 Solar Industries India LimitedSOLARINDS Open analysis | ₹1.81L | 90.93 | 0.06% | ₹3,668.00 | ₹666.00 | +70.29% | +88.67% |
Paradeep Phosphates Limited manufactures, trades, distributes, and sells urea and complex fertilizers in India. It offers di-ammonium phosphate; nitrogen, phosphorus, potassium fertilizers; muriate of potash; triple super phosphate; zypmite; phospho-gypsum; sulphuric acid; hydrofluorosilicic acid; and ammonia; as well as sulphur and zinc. It sells its products through dealers and retailers under the Navratna and Jai Kisaan brand names. The company was incorporated in 1981 and is based in Bengaluru, India. Paradeep Phosphates Limited is a subsidiary of Zuari Maroc Phosphates Private Limited.
IndiaBasic Materials
Is Paradeep Phosphates Limited Shariah compliant?
Paradeep Phosphates Limited is currently screened as Non-Compliant (Financial Ratios) under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (45.19%) exceeds AAOIFI threshold (≤ 33%).
What is Paradeep Phosphates Limited's current valuation relative to peers?
Paradeep Phosphates Limited trades at a P/E of 14.3x compared to the sector median of 21.9x, and a Price-to-Book of 2.3x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 1.02x. Interest coverage is 3.3x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.